News

23andMe to Be Bought by Biotech Company for $256 Million
Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...
Pharmaceutical company Regeneron buying 23andMe for $256 million
The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...
Regeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millions
It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly ...
Your 23andMe data is getting a new owner. Here's how to delete your account.
Me has found a buyer in biotech company Regeneron Pharmaceuticals. If you want your data removed, here are your options.
Rolling Out2d
The fall of 23andMe and what it means for your DNA
The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.
fox13now3d
Biotechnology company Regeneron buying 23andMe for $256 million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe ...